In vivo priming of IL-17 + uveitogenic T cells is enhanced by Toll ligand receptor (TLR)2 and TLR4 agonists via γδ T cell activation

Molecular Immunology

Volumn 50, Issue 3, 2012, Pages 125-133

  Zuo, Aijun ^a   Liang, Dongchun ^a   Shao, Hui ^b   Born, Willi K ^c   Kaplan, Henry J ^b   Sun, Deming ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Autoimmunity; EAU; Interleukin 17; Th17; Uveitis

Indexed keywords

INTERLEUKIN 17; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; DILUTION; ENVIRONMENTAL FACTOR; FEMALE; GAMMA DELTA T LYMPHOCYTE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH17 CELL; UVEITIS;

ANIMALS; CELL PROLIFERATION; FEMALE; INTERLEUKIN-17; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84857358229     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.12.013     Document Type: Article

References (45)

1. Abastado J.-P., Lone Y.-C., Casrouge A., Boulot G., Kourilsky P. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 1995, 182:439-447.
2. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
3. Allan D.S.J., Colonna M., Lanier L.L., et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 1999, 189:1149-1155.
4. Bettelli E., Oukka M., Kuchroo V.K. TH-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007, 8:345-350.
5. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of TH17 cells. Nature 2008, 453:1051-1057.
6. Bluestone J.A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995, 2:555-559.
7. Cerottini J.C., MacDonald H.R. Limiting dilution analysis of alloantigen-reactive T lymphocytes V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens. J. Immunol. 1981, 126:490-496.
8. Chow Y.H., Chiang B.L., Lee Y.L., et al. Development of Th1 and Th2 populations and the nature of immune response to hepatitis B virus DNA can be modulated by codelivery of various cytokine genes. J. Immunol. 1998, 160:1320-1329.
9. Cohen J.A., Essayan D.M., Zweiman B., Lisak R.P. Limiting dilution analysis of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell. Immunol. 1987, 108:203-216.
10. Constant S., Pfeiffer C., Woodard A., Pasqualini T., Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 1995, 182:1591-1596.
11. + uveitogenic T cells. J. Immunol. 2009, 183:560-567.
12. Del Pozo M.A., Sánchez-Mateos P., Sánchez-Madrid F. Cellular polarization induced by chemokines: a mechanism for leukocyte recruitment. Immunol. Today 1996, 17:127-131.
13. Dong Kim K., Zhao J., Auh S., et al. Adaptive immune cells temper initial innate responses. Nat. Med. 2007, 13:1248-1252.
14. Fazekas D.S. The evaluation of limiting dilution assays. J. Immunol. Methods 1982, 49:R11-R23.
15. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science 1996, 272:50-54.
16. Harrington L.E., Hatton R.D., Mangan P.R., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
17. Iezzi G., Karjalainen K., Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998, 8:89-95.
18. Iezzi G., Sonderegger I., Ampenberger F., Schmitz N., Marsland B.J., Kopf M. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:876-881.
19. Kelso A., MacDonald H.R., Smith K.A., Cerottini J.C., Brunner K.T. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures. J. Immunol. 1984, 132:2932-2938.
20. Komiyama Y., Nakae S., Matsuki T., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
21. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000, 290:92-97.
22. Lohr J., Knoechel B., Wang J.J., Villarino A.V., Abbas A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 2006, 203:2785-2791.
23. McMichael A.J., O'Callaghan C.A. A new look at T cells. J. Exp. Med. 1998, 187:1367-1371.
24. Nakamura T., Kamogawa Y., Bottomly K., Flavell R.A. Polarization of IL-4- and IFN-γ-producing CD4+ T cells following activation of naive CD4+ T cells. J. Immunol. 1997, 158:1085-1094.
25. + uveitogenic T cells. Invest. Ophthalmol. Vis. Sci. 2010, 51:4661-4667.
26. Nian H., Shao H., O'Brien B.A., Born W.K., Kaplan H.J., Sun D. Activated γδ cells promote the activation of uveitogenic T cells and exacerbate EAU development. Invest. Ophthalmol. Vis. Sci. 2011, 52:5920-5927.
27. Olsson T., Wang W.Z., Bo H., et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon. J. Clin. Invest. 1990, 86:981-985.
28. Park H., Li Z., Yang X.O., et al. A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
29. + interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2007, 48:4153-4161.
30. Romero P., Rod Dunbar P., Valmori D., et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 1998, 188:1641-1650.
31. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2001, 2:947-950.
32. Shao H., Liao T., Ke Y., Shi H., Kaplan H.J., Sun D. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp. Eye Res. 2006, 82:323-331.
33. Strominger J.L. Bacterial cell walls, innate immunity and immunoadjuvants. Nat. Immunol. 2007, 8:1269-1271.
34. Sun D., Wilson D.B., Cao L., Whitaker J.N. The role of regulatory T cells in Lewis rats resistant to EAE. J. Neuroimmunol. 1997, 78:69-78.
35. Sun D., Whitaker J.N., Wilson D.B. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease. Int. Immunol. 1999, 11:307-315.
36. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 2001, 166:7579-7587.
37. Sun D., Zhang Y., Wei B., Peiper S.C., Shao H., Kaplan H.J. Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules. Int. Immunol. 2003, 15:261-268.
38. Thurau S.R., Chan C.C., Nussenblatt R.B., Caspi R.R. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin. Exp. Immunol. 1997, 109:370-376.
39. Valitutti S., Müller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995, 375:148-151.
40. Vella A.T., Dow S., Potter T.A., Kappler J., Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3810-3815.
41. Viola A., Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996, 273:104-106.
42. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25:821-852.
43. Welch A.M., Holda J.H., Swanborg R.H. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remmision phase of the disease. J. Immunol. 1980, 125:186-189.
44. Wulfing C., Rabinowitz J.D., Beeson C., Sjaastad M.D., McConnell H.M., Davis M.M. Kinetics and extent of T cell activation as measured with the calcium signal. J. Exp. Med. 1997, 185:1815-1825.
45. Yi T., Chen Y., Wang L., et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 2009, 114:3101-3112.